Emergent Expands NARCAN Supply in BC Opioid Program
WINNIPEG, Manitoba, April 9, 2026 Emergent BioSolutions Inc. has announced a strategic partnership with the British Columbia Provincial Health...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
WINNIPEG, Manitoba, April 9, 2026 Emergent BioSolutions Inc. has announced a strategic partnership with the British Columbia Provincial Health...
LYON, France, April 09, 2026 Boehringer Ingelheim has announced its continued support for Ecuador’s national effort to eliminate dog-mediated...
WASHINGTON, D.C., April 3, 2026 The U.S. Food and Drug Administration (FDA), in collaboration with the Centers for Disease...
BASTROP, Texas, Feb. 2, 2026 — Low Cost Pet Vax announced the launch of an affordable community pet vaccination...
Chicago, Illinois | January 29, 2026 — IFMA The Food Away from Home Association has announced the nine winners...
Washington, D.C. | January 21, 2026 — The U.S. Food and Drug Administration (FDA) has taken a significant step...
New York City | January 12, 2026 — New York University has launched the Food Impact Program, a multidisciplinary...
Seattle and Vancouver, November 6, 2025 : Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company, announced...
Foster City, California – October 20, 2025 — Gilead Sciences, Inc. (Nasdaq: GILD) announced that it will present new...
Dateline – Silver Spring, MD, September 18, 2025 – The U.S. Food and Drug Administration (FDA), in coordination with...
